Real-world visual acuity outcomes for patients with naïve neovascular age-related macular degeneration treated with aflibercept, ranibizumab, or bevacizumab in the Republic of Korea
In the Korean clinical medical environment, which included various confounding factors, especially socioeconomic ones, the aflibercept VA outcome was significantly better than that of bevacizumab, and aflibercept injections were the most numerous. These real-world data imply that the drug effect as well as the environment in which the drug can be sufficiently used affected patient final VA scores.
Authors
- Ho Ra (ORCID: https://orcid.org/0000-0001-9671-2210)
- Mee Yon Lee (ORCID: https://orcid.org/0000-0002-6254-5466)
- Young‐Jung Roh (ORCID: https://orcid.org/0000-0001-7294-6813)
- Jae Yon Won (ORCID: https://orcid.org/0000-0002-8694-9043)
- Sung Pyo Park (ORCID: https://orcid.org/0000-0002-6978-0311)
- Yeo Jin Lee
- Seungbum Kang (ORCID: https://orcid.org/0000-0002-3632-108X)
- Dong Hyun Jee
Institutions
- Hallym University (KR)
- The Catholic University of Korea St. Vincent's Hospital (KR)
- Anyang Eye Hospital (CN)
- The Catholic University of Korea Uijeongbu St. Mary's Hospital (KR)
- The Catholic University of Korea Yeouido St. Mary's Hospital (KR)
- The Catholic University of Korea Bucheon St. Mary's Hospital (KR)
- Kangdong Sacred Heart Hospital (KR)
- Catholic University of Korea (KR)
Publication Details
- Journal
- PLoS ONE
- Published
- 2024-10-03
- DOI
- https://doi.org/10.1371/journal.pone.0310381
- Citations
- 1
- Primary Topic
- Retinal Diseases and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.54